Forxiga CKD Japan Post-Marketing Surveillance (PMS)

To capture safety when Forxige is administrated to CKD patients in the real world setting

The purpose of the study is to review the following points during use of Forxiga Tablets (hereinafter referred to as Forxiga) in the real world setting after launch for treatment of CKD. (1) ADRs which are unexpected from the precautions for use in our JPI (2) Understanding of incidence of ADRs during use of Forxiga in the real world setting (3) Factors (ie demography, treatment) possibly having an impact on the safety.